These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32400873)

  • 1. CD37 high expression as a potential biomarker and association with poor outcome in acute myeloid leukemia.
    Zhang Q; Han Q; Zi J; Song C; Ge Z
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32400873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis.
    Zhu F; Huang R; Li J; Liao X; Huang Y; Lai Y
    Med Sci Monit; 2018 Oct; 24():7100-7108. PubMed ID: 30289875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and clinical significance profile analysis of S100 family members in human acute myeloid leukemia.
    Yang XY; Jin J; Huang J; Li P; Xue JW; Wu XJ; He ZX
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7324-7334. PubMed ID: 32706071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia.
    Li K; Chen L; Zhang H; Wang L; Sha K; Du X; Li D; Zheng Z; Pei R; Lu Y; Tong H
    Aging (Albany NY); 2021 Apr; 13(8):11988-12006. PubMed ID: 33891561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody-Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML.
    Pereira DS; Guevara CI; Jin L; Mbong N; Verlinsky A; Hsu SJ; Aviña H; Karki S; Abad JD; Yang P; Moon SJ; Malik F; Choi MY; An Z; Morrison K; Challita-Eid PM; Doñate F; Joseph IB; Kipps TJ; Dick JE; Stover DR
    Mol Cancer Ther; 2015 Jul; 14(7):1650-60. PubMed ID: 25934707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
    Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J
    J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.
    Xu-Monette ZY; Li L; Byrd JC; Jabbar KJ; Manyam GC; Maria de Winde C; van den Brand M; Tzankov A; Visco C; Wang J; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Wang M; Hagemeister FB; Piris MA; Han van Krieken J; Medeiros LJ; Li Y; van Spriel AB; Young KH
    Blood; 2016 Dec; 128(26):3083-3100. PubMed ID: 27760757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.
    Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Yao DM; Zhang W; Lin J; Qian J
    J Cell Physiol; 2018 Jun; 233(6):4707-4714. PubMed ID: 29115660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia.
    Wang J; Hao JP; Uddin MN; Wu Y; Chen R; Li DF; Xiong DQ; Ding N; Yang JH; Ding XS
    Aging (Albany NY); 2021 Jun; 13(12):16445-16470. PubMed ID: 34148032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of ferroptosis-related genes and their methylation in AML.
    Zhou F; Chen B
    Hematology; 2021 Dec; 26(1):919-930. PubMed ID: 34789073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
    Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML.
    Ruvolo PP; Hu CW; Qiu Y; Ruvolo VR; Go RL; Hubner SE; Coombes KR; Andreeff M; Qutub AA; Kornblau SM
    EBioMedicine; 2019 Jun; 44():126-137. PubMed ID: 31105032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated approach of gene expression and DNA-methylation profiles of WNT signaling genes uncovers novel prognostic markers in acute myeloid leukemia.
    Taskesen E; Staal FJ; Reinders MJ
    BMC Bioinformatics; 2015; 16 Suppl 4(Suppl 4):S4. PubMed ID: 25734857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis and regulation of an adenylyl cyclase network in acute myeloid leukemia.
    Chen SL; Hu F; Wang DW; Qin ZY; Liang Y; Dai YJ
    Aging (Albany NY); 2020 Jun; 12(12):11864-11877. PubMed ID: 32568101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive DNA repair gene expression analysis and its prognostic significance in acute myeloid leukemia.
    Park S; Kim YJ; Huh HJ; Chung HS; Lee M; Park YM; Mun YC; Seong CM; Huh J
    Hematology; 2021 Dec; 26(1):904-913. PubMed ID: 34789078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA of vimentin expression as a valuable predictor for acute myeloid leukemia development and prognosis.
    Yi YY; Yi J; Zhu X; Zhang J; Zhou J; Tang X; Lin J; Wang P; Deng ZQ
    J Cell Physiol; 2019 Apr; 234(4):3711-3719. PubMed ID: 30152863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
    Shi JL; Fu L; Wang WD
    Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia.
    Shi J; Fu H; Jia Z; He K; Fu L; Wang W
    EBioMedicine; 2016 Dec; 14():55-64. PubMed ID: 27916548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
    Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of Wnt and Fzd gene families in acute myeloid leukaemia.
    Dai Y; Cheng Z; Fricke DR; Zhao H; Huang W; Zhong Q; Zhu P; Zhang W; Wu Z; Lin Q; Zhu H; Liu Y; Qian T; Fu L; Cui L; Zeng T
    J Cell Mol Med; 2021 Feb; 25(3):1456-1467. PubMed ID: 33417298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.